Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Collegium Pharma (NQ: COLL ) 39.21 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Collegium Pharma < Previous 1 2 Next > Collegium Completes Acquisition of Ironshore Therapeutics September 04, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference August 30, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024 August 28, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Reports Second Quarter 2024 Financial Results August 08, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology July 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024 July 25, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise June 13, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Participate in Jefferies Global Healthcare Conference May 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces $35 Million Accelerated Share Repurchase Program May 13, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Reports First Quarter 2024 Financial Results May 09, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces CEO Transition May 09, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER April 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report First Quarter 2024 Financial Results on May 9, 2024 April 25, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026 April 11, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference April 03, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results February 22, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024 February 08, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Provides 2024 Financial Guidance January 03, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent November 27, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces $25 Million Accelerated Share Repurchase Program November 09, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Participate in Upcoming Investor Conferences November 08, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Reports Third Quarter 2023 Financial Results November 07, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023 October 24, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023 August 28, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026 August 24, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces $50 Million Accelerated Share Repurchase Program August 07, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year August 03, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023 July 20, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Participate in Jefferies Healthcare Conference June 01, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Reports First Quarter 2023 Financial Results May 04, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.